Floatz logo

Edoxaban

Intracranial Hemorrhages

Population Health Research InstituteSmall moleculePhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

39 Active assets in the Intracranial Hemorrhages cohort.

Asset / SponsorPhaseRating
Tranexamic Acid
Christian Medical College and Hospital, Ludhiana, India
Phase 4BB
Acetylsalicylic Acid
University Hospital, Lille
Phase 4BB
Rivaroxaban
Imperial College London
Phase 3BB
Valproic Acid
Wolfson Medical Center
Phase 4BB
Valproic Acid
University of North Carolina, Chapel Hill
Phase 4BB

View all 50 →

Same molecule, other indications

Edoxaban is also rated in:

atrial fibrillationDormant
A
Indicative ·
83 / 100
View asset →
EmbolismDormant
BBB
Indicative ·
75 / 100
View asset →
atrial flutterDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →